Variant report
Variant | esv1795068 |
---|---|
Chromosome Location | chr7:145308227-145331508 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:4)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:4 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr7:145329048..145330913-chr7:145333895..145335425,2 | K562 | blood: | |
2 | chr7:145327982..145331284-chr7:145331722..145336898,4 | K562 | blood: | |
3 | chr7:145320589..145323367-chr7:145325718..145327864,2 | K562 | blood: | |
4 | chr7:145320589..145323367-chr7:145325718..145327864,2 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs139719596 | chr7:145320846-145320847 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs371086819 | chr7:145320850-145320851 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs551710862 | chr7:145320867-145320868 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs570111340 | chr7:145320910-145320911 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs115855290 | chr7:145320921-145320922 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs550977323 | chr7:145320961-145320962 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs569562269 | chr7:145321102-145321103 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs536410163 | chr7:145321152-145321153 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs555210300 | chr7:145321154-145321155 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs566923639 | chr7:145321181-145321182 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs10234759 | chr7:145321200-145321201 | Enhancers | n/a | n/a | Overlapped CNVs | mRNA abundance |
12 | rs186209111 | chr7:145321237-145321238 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs116802783 | chr7:145321259-145321260 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs148293374 | chr7:145321279-145321280 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs541850515 | chr7:145321286-145321287 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs556153957 | chr7:145321293-145321294 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs79062220 | chr7:145321304-145321305 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs149960176 | chr7:145321350-145321351 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs559921025 | chr7:145321357-145321358 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs12112078 | chr7:145321374-145321375 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs557360159 | chr7:145321405-145321406 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs545486125 | chr7:145321434-145321435 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs115092170 | chr7:145321510-145321511 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs191063027 | chr7:145321533-145321534 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs79238258 | chr7:145321592-145321593 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs142328514 | chr7:145321611-145321612 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs530420899 | chr7:145321619-145321620 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs548945654 | chr7:145321621-145321622 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs547329844 | chr7:145321680-145321681 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs567060565 | chr7:145321742-145321743 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs534427202 | chr7:145321753-145321754 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs181366683 | chr7:145321765-145321766 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs146806245 | chr7:145321767-145321768 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs850480 | chr7:145321789-145321790 | Flanking Active TSS Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
35 | rs556533583 | chr7:145321807-145321808 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs368319583 | chr7:145321819-145321820 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs535360464 | chr7:145321838-145321839 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs186785651 | chr7:145321912-145321913 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs566179674 | chr7:145321927-145321928 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs571896114 | chr7:145321941-145321942 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs545621364 | chr7:145321951-145321952 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs563999111 | chr7:145321954-145321955 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs140620805 | chr7:145321968-145321969 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs545915920 | chr7:145321978-145321979 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs114057775 | chr7:145322057-145322058 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs561720210 | chr7:145322084-145322085 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs145612338 | chr7:145322087-145322088 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs548882770 | chr7:145322115-145322116 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs147513388 | chr7:145322126-145322127 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs560793034 | chr7:145322130-145322131 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular cancer | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Autism | 19415332 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Malaria | 21533027 | CNVD |
Melanoma | 18172304 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
head and neck squamous cell carcinoma | 19289630 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Wilms tumour | 21544195 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Low-grade fibromyxoid sarcoma | 0 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Breast cancer | 21264507 | CNVD |
Shwachman-Diamond syndrome | 22934832 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Cutaneous malignant melanoma | 17690212 | CNVD |
Leukemia | 17361228 | CNVD |
Breast cancer | 16461572 | CNVD |
Peripheral t-cell lymphoma | 19118030 | CNVD |
Malignant melanoma | 17690212 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
abortions and stillbirths | 19751515 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Prostate cancer | 16573809 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
abnormal development | 18461090 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Papillary thyroid carcinoma | 21436994 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Non-syndromic sensorineural hearing loss | 18496225 | CNVD |
Hodgkin''s lymphoma | 18179710 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Breast cancer | 16272173 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Stuttering | 21108403 | CNVD |
Breast cancer | 17603634 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Myelodysplastic syndrome | 17634407 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Breast cancer | 17133270 | CNVD |
Schizophrenia | 17646849 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Heart disease | 21282601 | CNVD |
Lung adenocarcinoma | 17086460 | CNVD |
Gastric adenocarcinoma | 19115996 | CNVD |
Pancreatitis | 21956041 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Gastric cancer | 16891809 | CNVD |
Lung cancer | 17086460 | CNVD |
Autism | 19546859 | CNVD |
Schizophrenia | 19546859 | CNVD |
Tourette syndrome | 19546859 | CNVD |
Cancer | 20164920 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr7:145320800-145321400 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
2 | chr7:145321200-145322600 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
3 | chr7:145321400-145322000 | Flanking Active TSS | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
4 | chr7:145322000-145322800 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |